# Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children.

> **NCT04922476** · NA · COMPLETED · sponsor: **PrecisionBiotics Group Ltd.** · enrollment: 65 (actual)

## Conditions studied

- Functional Gastrointestinal Disorders
- Functional Abdominal Pain

## Interventions

- **DIETARY_SUPPLEMENT:** Alflorex®

## Key facts

- **NCT ID:** NCT04922476
- **Lead sponsor:** PrecisionBiotics Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-06
- **Primary completion:** 2023-03-04
- **Final completion:** 2023-04-04
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2023-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04922476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04922476, "Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04922476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*